These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 2745247)
1. Lack of extracellular slime effect on treatment outcome of Staphylococcus epidermidis experimental endocarditis. Steckelberg JM; Keating MR; Rouse MS; Wilson WR J Antimicrob Chemother; 1989 Jan; 23(1):117-21. PubMed ID: 2745247 [TBL] [Abstract][Full Text] [Related]
2. The effect of slime production on vancomycin efficacy in the treatment of experimental endocarditis due to Staphylococcus epidermidis. Baddour LM; Christensen GD; Schadow KH J Antimicrob Chemother; 1989 Sep; 24(3):365-73. PubMed ID: 2808192 [TBL] [Abstract][Full Text] [Related]
3. Therapy for experimental endocarditis due to Staphylococcus epidermidis. Kobasa WD; Kaye KL; Shapiro T; Kaye D Rev Infect Dis; 1983; 5 Suppl 3():S533-7. PubMed ID: 6635444 [TBL] [Abstract][Full Text] [Related]
4. Daptomycin is effective for treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus epidermidis. García-de-la-Mària C; Marco F; Armero Y; Soy D; Moreno A; del Río A; Almela M; Cervera C; Ninot S; Falces C; Mestres CA; Gatell JM; Jiménez de Anta MT; Miró JM; Antimicrob Agents Chemother; 2010 Jul; 54(7):2781-6. PubMed ID: 20421394 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus. Madrigal AG; Basuino L; Chambers HF Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918 [TBL] [Abstract][Full Text] [Related]